Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Chronic myeloid leukemia"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Xu%2C+Na%22&type=Person&filter%5B%5D=topic_facet%3A%22Chronic+myeloid+leukemia%22
/vufind/Search/Results?lookfor=%22Xu%2C+Na%22&type=Person&filter%5B%5D=topic_facet%3A%22Chronic+myeloid+leukemia%22
Search /vufind/Search2/Results?lookfor=%22Xu%2C+Na%22&type=Person&filter%5B%5D=topic_facet%3A%22Chronic+myeloid+leukemia%22
PubPharm (16)
1
Patient Versus Physician Perspective in the Management of Chronic Myeloid Leukemia During Treatment with Tyrosine Kinase Inhibitors
enthalten in:
Oncology and therapy
| 2024
von
Chen, H.
|
Wen, Y.
|
Zeng, Y.
| +22
Wird geladen...
2
Patient Versus Physician Perspective in the Management of Chronic Myeloid Leukemia During Treatment with Tyrosine Kinase Inhibitors
enthalten in:
Rare Cancers and Therapy
| 2023
von
Chen, H.
|
Wen, Y.
|
Zeng, Y.
| +22
Wird geladen...
3
Evaluation of physician guideline adherence and areas for improvement in managing patients with chronic myeloid leukemia : a cross-sectional survey
enthalten in:
Leukemia & lymphoma
| 2023
von
Chen, H.
|
Zhang, Y.
|
Jiang, Y.
| +12
Wird geladen...
4
Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia : results of an open-label, multicenter phase 1/2 trial
enthalten in:
Journal of hematology & oncology
| 2022
von
Jiang, Q.
|
Li, Z.
|
Qin, Y.
| +20
ErratumIn: J Hematol Oncol. 2022 Oct 31;15(1):159. - PMID 36316695
Wird geladen...
5
Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial
enthalten in:
Journal of hematology & oncology
| 2022
von
Jiang, Q.
|
Li, Z.
|
Qin, Y.
| +20
Wird geladen...
6
Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial
enthalten in:
Journal of hematology & oncology
| 2022
von
Jiang, Q.
|
Li, Z.
|
Qin, Y.
| +20
Wird geladen...
7
Adolescents experienced more treatment failure than children with chronic myeloid leukemia receiving imatinib as frontline therapy : a retrospective multicenter study
enthalten in:
Annals of hematology
| 2021
von
Dou, X.
|
Zheng, F.
|
Zhang, L.
| +23
Wird geladen...
8
Adolescents experienced more treatment failure than children with chronic myeloid leukemia receiving imatinib as frontline therapy: a retrospective multicenter study
enthalten in:
Annals of hematology
| 2021
von
Dou, X.
|
Zheng, F.
|
Zhang, L.
| +23
Wird geladen...
9
Adolescents experienced more treatment failure than children with chronic myeloid leukemia receiving imatinib as frontline therapy: a retrospective multicenter study
enthalten in:
Annals of hematology
| 2021
von
Dou, X.
|
Zheng, F.
|
Zhang, L.
| +23
Wird geladen...
10
Adolescents experienced more treatment failure than children with chronic myeloid leukemia receiving imatinib as frontline therapy: a retrospective multicenter study
enthalten in:
Annals of hematology
| 2021
von
Dou, X.
|
Zheng, F.
|
Zhang, L.
| +23
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Chronic myeloid leukemia
Medienart
16
Aufsätze
15
E-Artikel
15
E-Ressourcen
1
Gedruckte Aufsätze
Zeitschriftentitel
4
Annals of hematology
3
Journal of hematology & oncology
2
Leukemia & lymphoma
1
Biomedicine & pharmacotherapy
1
Biomedicine & pharmacotherapy = Biomedecine & p...
1
Blood cells, molecules & diseases
1
Journal of experimental & clinical cancer research
1
Journal of experimental & clinical cancer resea...
1
Oncology and therapy
1
Rare Cancers and Therapy
Alle anzeigen ...
weniger ...
Thema
Chronic myeloid leukemia
8
Journal Article
4
8A1O1M485B
4
Adolescents
4
Children
4
Drug resistance
4
Imatinib
4
Imatinib Mesylate
4
Protein Kinase Inhibitors
4
Research Support, Non-U.S. Gov't
3
Accelerated phase
3
Chronic phase
3
T315I mutation
3
Tyrosine kinase inhibitor
2
Autophagy
2
Chidamide
2
Discrepancies
2
EC 2.7.10.2
2
Energy metabolism
2
Fusion Proteins, bcr-abl
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
12
2020-
4
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
16
Englisch
Haven't found what you're looking for?
Wird geladen...